AURKA and malignant peripheral nerve sheath tumor: Our studies indicate that hemizygous loss of HMMR/RHAMM, which occurs in approximately 50% of aggressive MPNST [9], may oncogene-addict tumours to AURKA activity and sensitize these cancers to AKI.